首页 | 本学科首页   官方微博 | 高级检索  
检索        


Towards an improved investment approach for an effective response to HIV/AIDS
Authors:Schwartländer Bernhard  Stover John  Hallett Timothy  Atun Rifat  Avila Carlos  Gouws Eleanor  Bartos Michael  Ghys Peter D  Opuni Marjorie  Barr David  Alsallaq Ramzi  Bollinger Lori  de Freitas Marcelo  Garnett Geoffrey  Holmes Charles  Legins Ken  Pillay Yogan  Stanciole Anderson Eduardo  McClure Craig  Hirnschall Gottfried  Laga Marie  Padian Nancy;Investment Framework Study Group
Institution:Joint United Nations Programme on HIV/AIDS, Geneva, Switzerland. schwartlanderb@unaids.org
Abstract:Substantial changes are needed to achieve a more targeted and strategic approach to investment in the response to the HIV/AIDS epidemic that will yield long-term dividends. Until now, advocacy for resources has been done on the basis of a commodity approach that encouraged scaling up of numerous strategies in parallel, irrespective of their relative effects. We propose a strategic investment framework that is intended to support better management of national and international HIV/AIDS responses than exists with the present system. Our framework incorporates major efficiency gains through community mobilisation, synergies between programme elements, and benefits of the extension of antiretroviral therapy for prevention of HIV transmission. It proposes three categories of investment, consisting of six basic programmatic activities, interventions that create an enabling environment to achieve maximum effectiveness, and programmatic efforts in other health and development sectors related to HIV/AIDS. The yearly cost of achievement of universal access to HIV prevention, treatment, care, and support by 2015 is estimated at no less than US$22 billion. Implementation of the new investment framework would avert 12·2 million new HIV infections and 7·4 million deaths from AIDS between 2011 and 2020 compared with continuation of present approaches, and result in 29·4 million life-years gained. The framework is cost effective at $1060 per life-year gained, and the additional investment proposed would be largely offset from savings in treatment costs alone.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号